The China antibodies market is witnessing a paradigm shift characterized by remarkable growth and increasing innovation in biopharmaceuticals. It's projected to reach an impressive market value of 94.0 USD by 2035, reflecting a compound annual growth rate (CAGR) of 13.72%. As the demand for therapeutic options rises, particularly amidst chronic disease prevalence, this market is on the cusp of...